Hesong Zou
Overview
Explore the profile of Hesong Zou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu W, Zou H, Chen L, Huang W, Lv R, Xu Y, et al.
J Immunother Cancer
. 2024 Apr;
12(4).
PMID: 38631712
Background: Approximately two-thirds of patients with relapsed or refractory large B-cell lymphoma (R/R LBCL) do not respond to or relapse after anti-CD19 chimeric antigen receptor T (CAR T)-cell therapy, leading...
2.
Zou H, Liu W, Wang X, Wang Y, Wang C, Qiu C, et al.
J Immunother Cancer
. 2024 Mar;
12(3).
PMID: 38443094
Background: Over 50% of patients with relapsed or refractory large B-cell lymphoma (r/r LBCL) receiving CD19-targeted chimeric antigen receptor (CAR19) T-cell therapy fail to achieve durable remission. Early identification of...
3.
Liu H, Zou H, Shan D, Liu W, Huang W, Sui W, et al.
Cancer Med
. 2024 Feb;
13(2):e6965.
PMID: 38348996
Background: High-dose chemotherapy followed by autologous stem cell transplantation (ASCT) remains an effective treatment for non-Hodgkin lymphoma (NHL). The limited availability of carmustine has prompted the exploration of novel alternative...
4.
Zou H, Liu W, Wang Y, Shan D, Xie T, Li R, et al.
Chin Med J (Engl)
. 2023 Dec;
137(13):1620-1622.
PMID: 38061986
No abstract available.